Medical Science Liaison, Europe Central Region Field Based - Germany

About Bridge Bio Pharma, Inc.

Bridge Bio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease.

We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.

Bridge Bio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.

At Bridge Bio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.

You will report to the Senior Medical Director, Europe Central Region, and work closely with fellow Medical Science Liaisons, local Market Access, and regional and global Medical Affairs teams. Together, you will execute the Medical Affairs brand plan and strategic initiatives that support Bridge Bio’s mission to deliver transformative medicines for patients with genetic diseases and genetically driven cancers.

Your primary purpose will be to build our KOL and HCP base in the pre-launch and launch phase, as Bridge Bio engages with most customers in Germany for the first time. You will work on our initiatives during early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, engage with HCPs to increase diagnosis rates and support market access related work as a key stakeholder.

This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech company for the first time to KOLs, medical and scientific engagement and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition.

We look for strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.

• Identify relevant HCPs and map the treatment landscape in scope, including patient journey with diagnosis, treatment, referral and centers of excellence
• Deliver pre-launch activities to ensure medical readiness, including disease state education, unmet need articulation, initiatives to significantly improve diagnosis rates, and structured scientific exchange planning and KOL engagement
• Support identification, prioritization, and delivery of high-impact medical research initiatives aligned with business objectives, including Bridge Bio-sponsored and investigator-initiated studies, for generation of locally relevant data
• Co-design and deliver insight-generation and medical education activities, including advisory boards, congress symposia, standalone meetings, hospital-based education, and speaker development programs
• Leverage AI and digital technologies to enhance medical insights generation, stakeholder engagement, knowledge management, and operational efficiency, ensuring compliant, ethical, and value-driven use of emerging digital solutions
• Regular review of relevant literature, participation in scientific congresses and conferences, including Bridge Bio therapeutic area training sessions to maintain current knowledge and to develop competitive intelligence on other…